РЕАЛЬНІ ГОРИЗОНТИ ПЕРСОНАЛІЗОВАНОЇ МЕДИЦИНИ. СТРАТЕГІЯ ТА ВАРІАНТИ РОЗВИТКУ
Анотація
Ключові слова
Повний текст:
PDFПосилання
Apanasenko, G., Gavrilyuk, V. (2014). Biologicheskaya degradatsiya HOMO SAPIENS: puti protivodeistviya. Osnovy. Kontseptsii. Metody [The biological degradation of the Homo Sapiens: the path of resistance. Fundamentals. Concept. Methods]. Saarbrücken: Palmarium Academic Publishing. [In Russian].
The European health report 2015. Targets and beyond — reaching new frontiers in evidence. (14.07.2015). Retrieved from http://www.euro. who.int/ru/data-and-evidence/european-health-report2015 [In Russian].
Dedov, I. I., Tyul'pakov, A. I., Chekhonin, V. P., Baklaushev, V. P., Archakov, A. I., Moshkovskii, S. A. (2012). Personalized medicine: state-of-the-art and prospects. Annals of the Russian academy of medical sciences, 67(12), 4–12. [In Russian]. doi:10.15690/vramn.v67i12.474
Berg, J. S., Khoury, M. J. & Evans, J. P. (2011). Deploying whole genome sequencing in clinical practice and public health: Meeting the challenge one bin at a time. Genetics in Medicine , 13(6), 499–504. doi: 10.1097/GIM.0b013e318220aaba.
Chan, I. S. & Ginsburg, G. S. (2011). Personalized medicine: progress and promise. Annu. Rev. Genomics Hum. Genet., 12, 217–244. doi: 10.1146/annurev-genom-082410-101446.
Garrison, Jr. L. P. & Austin, M. J. (2007). The economics of personalized medicine: a model of incentives for value creation and capture. Drug Information Journal, 41, 501–509.
Hamburg, M. A. & Collins, F. S. (2010). The path to personalized medicine. N. Engl. J. Med., 363(4), 301–304. doi: 10.1056/NEJMp1006304.
Hoggatt, J. (2011). Personalized medicine trends in molecular diagnostics: exponential growth expected in the next ten years. Mol. Diagn. Ther., 15(1), 53–55. doi: 10.2165/11534880-000000000-00000.
Jain, K. K. (2002). From molecular diagnostics to personalized medicine. Exp. Rev. Mol. Diagn., 2(4), 299–301.
Jain, K. K. (2011). Nanobiotechnology and personalized medicine. Prog. Mol. Biol. Transl. Sci., 104, 325–354. doi: 10.1016/B978-0-12-416020-0.00008-5
Nebert, D. W. & Zhang, G. (2012). Personalized medicine: temper expectations. Science, 337(6097), 910. doi: 10.1126/science.337.6097.910-a.
Nishiyama, M. (2010). Personalized medicine and molecular targets of drugs. Nihon Rinsho, 68(10), 1917–1922.
Mirnezami, R., Nicholson, J. & Darzi, A. (2012). Preparing for precision medicine. N. Engl. J. Med., 366(6), 489-491. doi: 10.1056/NEJMp1114866
Miranda, D. M., Mamede, M., Souza, B. R., Almeida Barros, A. G., Magno, L. A., Alvim-Soares, Jr. A, … Romano-Silva, M. A. (2012). Molecular medicine: a path towards a personalized medicine. Rev Bras. Psiquiatr., 34(1), 82–91.
Pollack, A. (2010, November 16). Drug companies pursue personalized medicine approach. New York Times. Retrieved from https://prescriptions.blogs.nytimes.com/2010/11/16/drug-companies-pursue-personalized-medicine-approach/
Scudellari, M. (2012). Genomics contest underscores challenges of personalized medicine. Nat. Med., 18(3), 326. doi: 10.1038/nm0312-326
Spear, B. B., Heath-Chiozzi, M. & Huff, J. (2001). Clinical application of pharmacogenetics. Trends Mol. Med., 7(5), 201–204.
DOI: http://dx.doi.org/10.11603/mie.1996-1960.2016.4.7054
Посилання
- Поки немає зовнішніх посилань.
##submission.copyrightStatement##